InsidersTradesSigma
Discover the full record of transactions filed by Stephens Kristin, Directeur du Développement. Insider active across 1 companies, notably Syros Pharmaceuticals, Inc.. In total, 1 disclosures have been published. The latest transaction was disclosed on 1 April 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Kristin Stephens is the Chief Development Officer at Syros Pharmaceuticals, Inc. She is responsible for the company's development strategy, which focuses on drug discovery. Kristin brings expertise in research and development, contributing to the innovation and advancement of the company's projects.